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Abstract
Nitric oxide synthase (NOS) catalyzes the production of nitric oxide from L-arginine and dioxygen
at a thiolate-ligated heme active site. Although many of the reaction intermediates are as yet
unidentified, it is well established that the catalytic cycle begins with substrate binding and rate-
limiting electron transfer to the heme. Here we show that Ru(II)-diimine and Re(I)-diimine electron
tunneling wires trigger nanosecond photoreduction of the active-site heme in the enzyme. Very rapid
generation of a reduced thiolate-ligated heme opens the way for direct observation of short-lived
intermediates in the NOS reaction cycle.
INTRODUCTION
Salvador Moncada and colleagues reported in 1987 that the molecule responsible for relaxation
of blood vessels is nitric oxide (NO).1 This publication marked the beginning of a new area of
chemical and biological research, with thousands of articles published each year. Long known
as a cytotoxic agent in pathological processes,2 NO now is recognized as a key signaling
molecule in the cardiovascular, immune, and nervous systems.3
Nitric oxide synthases (NOSs) are responsible for the production of NO in living systems.4
The three (mammalian) isoforms of the enzyme are named for the tissues in which they are
found: endothelial NOS (eNOS), neuronal (nNOS), and an inducible form found in
macrophages (iNOS). The functions of eNOS and nNOS are regulated by calcium ions and a
calmodulin linker, while the inducible isoform is calcium ion independent.5 NOSs catalyze the
oxidation of L-arginine (Arg) to L-citrulline in two turnovers, with Nω-hydroxy-L-arginine
(NHA or ArgOH) as an enzyme-bound intermediate (the product of the first turnover).6 The
overall reaction is shown in Scheme 1.
All three isoforms are found as homodimers, each monomer consisting of an oxygenase and a
reductase domain.8 The reductase domain binds flavin adenine dinucleotide (FAD) and flavin
mononucleotide (FMN), cofactors that shuttle electrons from nicotinamide adenine
dinucleotide phosphate (NADPH),9 the ultimate source of electrons for the reaction, to the
oxygenase domain where substrate oxidation occurs. The oxygenase domain contains a
thiolate-ligated heme (protoporphyrin IX, or P-IX) as in cytochromes P450 (P450) and (6R)
−5,6,7,8-tetrahydrobiopterin (pterin, H4B).8 NO is produced when this domain is supplied with
electrons from the reductase domain to activate dioxygen,10 and in the presence of fully reduced
pterin cofactor.11, 12 Although structural characterization of full-length NOS has not been
reported to date, structures of individual domains are known.13, 14
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The mechanism of NO production is incompletely understood.15 The resting state of the
enzyme is a six-coordinate ferric heme with a water molecule occupying the sixth ligand
position (four positions are occupied by N donors from the porphyrin, one by a sulfur atom
from an axial cysteine, Cys194).16 Although neither Arg nor ArgOH ligates the heme, substrate
binding shifts both the Soret absorption maximum and the heme spin state.7, 17 One-electron
reduction of the NOS:substrate complex gives a five-coordinate ferrous that readily binds
dioxygen, forming a ferrous-oxy species (equivalent to ferric superoxide),8 the last observed
intermediate in the catalytic cycle.8, 18
The role of pterin has been extensively investigated.11, 16, 19 This molecule binds in a pocket
alongside the heme, forming hydrogen bonds with a P-IX carboxylate, thereby coupling it to
the active site.13 It is known that a pterin-based radical forms and is reduced during the catalytic
cycle, as determined by analysis of results from rapid-freeze EPR experiments.12, 20 Turnover
has never been observed without fully reduced pterin cofactor.21
The NOS reaction cycle bears many similarities to that of P450s. P450s contain thiolate-heme
active sites and hydroxylate substrates via two-electron oxidation processes.22, 23 The P450
cycle also begins with substrate binding followed by heme reduction, dioxygen binding, and
another reduction step leading to the formation of a high-valent iron-oxo complex (Compound
I) that hydroxylates the substrate (Scheme 2).23 Separate enzymes serve as reductases for
P450s, but substrate hydroxylation can be driven using external sources of electrons.24 Owing
to these similarities, the mechanism of the first turnover of NOS is postulated to be the same
as that of P450s.25 However, the second turnover, a three-electron oxidation, is thought to
employ a unique mechanism.26 It has been suggested that a protonated ferric hydroperoxide
may act as the nucleophile in the second turnover18 rather than Compound I, which is a ferryl
P-IX radical cation.8
Steps in the mechanistic cycle borrowed from P450 are shown in Scheme 2. Although several
intermediates in the P450 cycle already have been observed, there can be no doubt that “the
hunt for an unambiguous experimental identification of the ephemeral active oxygen species
will most certainly continue.”22 If that is the case for P450, then we may conclude that work
on the NOS catalytic cycle is just beginning.
A long-standing goal in our group is the development of methods to generate and observe high-
valent iron-oxo complexes that are believed to play key roles as intermediates in the catalytic
cycles of heme enzymes.27 Direct observation during turnover would allow definitive
identification of the active oxidant. Drawing on studies of similar enzymes and using EPR
under cryogenic conditions and X-ray crystallography, investigators have amassed a large body
of evidence that strongly indicates that Compound I (Scheme 2, the ferryl P-IX racial cation
shown in red) is the active species.28 The steps leading to formation of this highly reactive
species are slow, making its observation problematic, as at best it is present in very low
concentrations during catalysis.
We have investigated the redox photochemistry of two heme enzymes, microperoxidase-8
(MP-8, a heme octapeptide fragment of cytochrome c) and horseradish peroxidase (HRP).29
Visible excitation of Ru(bpy)32+ (bpy is 2,2′-bipyridine) in the presence of oxidative quenchers
in solution generates a powerful Ru(III)-diimine oxidant, which reacts rapidly with P-IX to
form the P-IX radical cation, which then oxidizes Fe(III) to give high-valent iron-oxo
complexes of MP-8 and HRP.29, 30 Attempts to generate high-valent hemes in P450s in
reactions with uncomplexed photogenerated oxidants were not successful so we changed
course, as discussed in the following section.
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Since 1999 we have developed sensitizer-linked electron tunneling wires that are able to deliver
electrons and holes rapidly to and from deeply buried active sites of heme enzymes.31, 32
Attaching the photosensitizer to the substrate promotes a close interaction between the two,
and increases the probability of ET (Figure 1). A selection of such molecules developed for
the oxygenase domain of iNOS is shown in Chart 1.
The dissociation constants of complexes that contain wires in the substrate channels of enzymes
can be determined from analysis of shifts in Soret absorptions. Examples of these shifts in the
case of iNOSoxy are shown in Figure 2.34
The wires luminesce upon 355 nm (Re(I)) or 480 nm (Ru(II)) excitation. The emission overlap
with heme absorptions triggers Forster energy transfer (FET), which accounts for the steady-
state emission quenching observed upon binding of wires to iNOSoxy (Figure 3).34
Transient absorption measurements demonstrate that these wires reduce iNOSoxy upon 355
or 480 nm excitation. Reduction is indicated by a bleach near 420 nm, corresponding to the
disappearance of the six-coordinate Fe(III) resting state and the formation of a new species
(with absorption near 445 nm) assigned to six-coordinate Fe(II). Difference spectra were
constructed from single-wavelength transient absorption traces 80 ns after excitation of the
protein-bound wire 7 (Figure 3, blue) and 3 μs after excitation of protein-bound wire 5 (Figure
4, red).
Picosecond transient absorption measurements demonstrate rapid formation of Fe(II) in the
presence of wires 5 and 7. By pumping with 70 ps, 355 nm pulses and probing with 442 nm
radiation from a continuous wave He:Cd laser, we obtained transient absorbance traces that
document the formation of a ferrous heme on very short timescales (Figure 5). The traces were
fit to a single exponential to give kf = 7(3) × 109 s−1 for formation of Fe(II).
Although the demonstration of very rapid electron transfer to a heme active site represents a
step toward the goal of observing high-valent intermediates, our electron delivering wires block
access to substrate channels (Figure 6).33 We have exploited this property of channel binders
in the construction of highly selective amine oxidase inhibitors by manipulation of the linker
elements of wire structures.35
SURFACE-BINDING WIRES
We are investigating wires that bind on enzyme surfaces, as they are much less likely to impede
substrate binding (Chart 2). The luminescence of wire 9 is quenched upon binding to iNOSoxy
(Figure 7), and addition of channel binder 5 does not alter the decay rate.
Upon electronic excitation, surface binders 9–12 trigger ET without blocking substrate or
cofactor binding, maintaining the potential for enzymatic turnover.
We have shown that 9 binds to iNOSoxy independently of substrate and pterin with a
dissociation constant of < 1 μM.34 Binding distant from the active site is demonstrated by the
finding that a known channel binder does not displace 9 from the enzyme.34 While the precise
binding site has not been definitively established, FET measurements indicate that it may be
in the hydrophobic pocket thought to be the docking site for the iNOS reductase domain.34,
37 Experiments with Ru(bpy)32+ show that the sensitizer alone does not bind to the enzyme,
suggesting that the perfluorobiphenyl unit is largely responsible for the association of the wire
with a hydrophobic iNOSoxy surface region.
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Single-wavelength transient absorbance measurements with imidazole-bound iNOSoxy in the
presence of one equivalent of 9, 10 mM ascorbate, and saturated tetramethylphenylenediamine
(TMPD) confirm that Fe(II) forms within 50 ns of excitation at 480 nm (Figure 9).38 A
difference spectrum constructed from the single-wavelength data at 2 μs (Figure 10) shows the
bleach of the imidazole-Fe(III) Soret absorption peak at 428 nm and the development of the
imidazole-Fe(II) feature at 445 nm. Control experiments with Ru(bpy)32+ demonstrate that the
perfluorobiphenyl moiety of 9 is required for heme reduction. In the presence of Ru(bpy)32+
and quenchers, transient absorbance traces show only the production of Ru(I).38
To estimate the specific rate of Fe(II) formation, *Ru(II) contributions were subtracted from
the transient absorbance data.38 Representative traces are shown in Figure 11. The traces were
fit to a single-exponential function to obtain kET = 2(1) × 107 s−1.
This is a remarkably fast reduction given the estimated Ru-Fe distance of 20.2 Å34 and the
absence of a through-bond pathway to the heme. Given its slim profile, hydrophobicity, and
potential to π-stack with aromatic residues, the perfluorobiphenyl moiety of 9 could penetrate
into the protein interior, leaving open the possibility of a through-wire hopping mechanism.18
CONCLUSIONS
We have developed a system in which the heme of inducible nitric oxide synthase can be
photoreduced rapidly without interfering with substrate or cofactor binding. Employing flash-
quench experiments with a surface-binding Ru-diimine wire in combination with reductive
quenchers, we observed ET to the imidazole-bound heme of iNOSoxy fully seven orders of
magnitude faster than the natural reduction. This finding represents an important step toward
our goal of identifying reactive intermediates in the catalytic cycles of heme oxotransferases.
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Substrates linked to sensitizers target active-site channels of enzymes.
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UV-visible absorption spectra of iNOSoxy: wire complexes. (A) iNOSoxy alone (5 μM; black)
and bound to 1 equivalent each of 5 (red) and 4 (blue). (B) iNOSoxy alone (5 μM; black) and
bound to 1 equivalent each of 7 (red) and 6 (blue).
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Steady-state luminescence spectra of 5 (2 μM; blue) and a 1:1 mixture of 5 and iNOSoxy (2
μM; red) with λex = 355 nm.
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Difference spectra of a 1:1 mixture of 7 and iNOSoxy (5 μM, 80 ns after 355 nm excitation,
blue squares) and a 1:1 mixture of 5 and iNOSoxy (11 μM, 3 μs after 355 nm excitation, red
triangles) showing a bleach of a six-coordinate Fe(III) Soret (420 nm) and the appearance of
a six-coordinate Fe(II) Soret (445 nm). Individual points were taken from single-wavelength
transient absorption traces.
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Transient absorbance at 442 nm of iNOSoxy alone (8 μM, blue) and in the presence of excess
5 (red) with λex = 355 nm. The red trace shows the rapid formation of ferrous heme fit to one
exponential (kf = 7(3) × 109 s−1 black) with the residual shown above.
Whited et al. Page 10














Structural model of Re-perfluorobiphenyl wire 5 in the substrate channel of iNOSoxy.36
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Transient decay data for 9 (blue) and a 1:1 mixture of 9 and iNOSoxy (1.8 μM; green). The
fast component of the luminescence decay is assigned to the complex between 9 and iNOSoxy.
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Transient luminescence decay data for a 2:1 mixture of 9 with iNOSoxy (black) and a 2:1:1
mixture of 9, 5, and iNOSoxy (gray). In the second mixture, 5 was shown by UV-visible
absorption spectroscopy to be bound in the active site. Since the luminescence decay of 9 was
not disturbed by the binding of 5, these traces indicate that 9 does not bind in the active-site
channel.
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Transient absorbance of quenched imidazole-iNOSoxy bound to 1 equivalent of 9 (11 μM with
10 mM ascorbate and saturated TMPD). λex = 480 nm.
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Transient absorbance of a 1:1 mixture of imidazole-iNOSoxy and 9 (22 μM with 10 mM
ascorbate and saturated TMPD) showing a characteristic Fe(III/II) difference spectrum.
Individual points were taken from single-wavelength transient absorbance traces, 2 μs after
480 nm excitation.
Whited et al. Page 15














Transient absorbance of imidazole-iNOSoxy bound to 1 equivalent of 9 (11 μM with 10 mM
ascorbate and saturated TMPD) corrected for absorbance due to *Ru(II) to reveal kET = 2(1)
× 107 s−1.
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The five-electron oxidation of arginine to form NO and citrulline.7
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Proposed NOS catalytic cycle; active-site intermediates that have not been observed are shown
in red.
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Ru(II) and Re(I) electron tunneling wires bind to the oxygenase domain of murine inducible
nitric oxide synthase (iNOSoxy).18, 33
Whited et al. Page 19














Four wires that bind on iNOSoxy surfaces.
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